Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part III: Clinical and analytical recommendations for the study of monoclonal gammopathies by MALDI-TOF mass spectrometry.
Saved in:
| Title: | Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part III: Clinical and analytical recommendations for the study of monoclonal gammopathies by MALDI-TOF mass spectrometry. |
|---|---|
| Authors: | Agulló C; Department of Clinical Biochemistry, 37479 Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL) , Salamanca, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Puig N; Hematology Department, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Instituto de Biología Molecular y Celular del Cáncer (Universidad de Salamanca-Consejo Superior de Investigaciones Científicas), CIBERONC, Salamanca, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain., Varo N; Department of Clinical Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Iglesias MÁ; Department of Clinical Biochemistry, Hospital 12 de Octubre, Madrid, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Mugueta C; Department of Clinical Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain., Pello R; Department of Clinical Biochemistry, Hospital 12 de Octubre, Madrid, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Paiva B; Clínica Universidad de Navarra (CCUN), Centro de Investigación Medica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain., Martínez-López J; Hematology Department, Hospital Universitario 12 de Octubre, Complutense University, i+12, Centro Nacional de Investigaciones Oncológicas, Centro de Investigación Biomédica en Red (CIBERONC), CB16/12/00369, Madrid, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain., Castro S; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Cárdenas MC; Department of Clinical Analysis, Hospital Clinico San Carlos, Madrid, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., García-Sanz R; Hematology and Hemotherapy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Facultad de Medicina, Universidad Complutense de Madrid (UCM), Madrid, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain., Pérez-Surribas D; Laboratori Pasteur, Andorra La Vella, Andorra.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Flores-Montero J; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain., Ortiz-Espejo M; Department of Clinical Biochemistry, Hospital Universitario Marqués de Valdecilla, Santander, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., de la Rubia J; Hematology Department, University Hospital La Fe and School of Medicine and Dentistry, Catholic University of Valencia; Instituto de Investigación Sanitaria La Fe, València, Spain; CIBERONC CD16/12/00284, Valencia, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain., Cruz-Iglesias E; Department of Clinical Biochemistry, Hospital Universitario de Basurto, Osakidetza, Bilbao, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Fontán A; Department of Clinical Biochemistry, Hospital Universitario Miguel Servet, Zaragoza, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Isidoro-García M; Department of Clinical Biochemistry, University Hospital of Salamanca, Salamanca, Spain.; Medicine Department, University of Salamanca, Salamanca, Spain.; Institute for Biomedical Research of Salamanca, Salamanca, Spain.; Pharmacogenetics and Precision Medicine Unit, Results-Oriented Cooperative Research Networks in Health, Carlos III Health Institute, Madrid, Spain., San-Miguel J; Hematology Department, Cancer Center Clínica Universidad de Navarra (CCUN), CIMA, IDISNA, Pamplona, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain., Mateos MV; Hematology Department, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Instituto de Biología Molecular y Celular del Cáncer (Universidad de Salamanca-Consejo Superior de Investigaciones Científicas), CIBERONC, Salamanca, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain. |
| Source: | Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2025 Nov 04; Vol. 64 (3), pp. 586-599. Date of Electronic Publication: 2025 Nov 04 (Print Publication: 2026). |
| Publication Type: | Journal Article; Practice Guideline |
| Journal Info: | Publisher: Walter De Gruyter Country of Publication: Germany NLM ID: 9806306 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1437-4331 (Electronic) Linking ISSN: 14346621 NLM ISO Abbreviation: Clin Chem Lab Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1437-4331 |
|---|---|
| DOI: | 10.1515/cclm-2025-1056 |
